BRIN Head: Vaccine Development Crucial for Health Sovereignty
BRIN Head, Professor Bambang Brodjonegoro, emphasized that vaccine development is fundamental to achieving health sovereignty. He highlighted the importance of domestic innovation in this sector, citing the collaboration between Tsinghua University and Indonesian researchers on an mRNA dengue vaccine as a catalyst for further advancements. This initiative aims to reduce reliance on foreign-produced vaccines and strengthen Indonesia's capacity to respond to health crises. Brodjonegoro stated that this collaboration is not just about developing a specific vaccine but also about building the infrastructure and expertise needed for future vaccine research and production within Indonesia. The goal is to ensure that Indonesia can independently develop and manufacture vaccines, thereby enhancing national security and public health resilience. He believes that investing in domestic vaccine capabilities will lead to greater control over public health policies and a more robust healthcare system capable of addressing emerging infectious diseases.
The push for domestic vaccine development, exemplified by the BRIN-Tsinghua collaboration on an mRNA dengue vaccine, reflects a global trend toward health sovereignty and reduced reliance on international supply chains. This strategic imperative is driven by lessons learned during recent pandemics, where access to essential medical supplies became a geopolitical concern. By fostering local R&D and manufacturing, Indonesia aims to build resilience against future health emergencies and potentially capture economic benefits from its own pharmaceutical industry. The challenge lies in balancing the significant investment required for cutting-edge biotechnology with the immediate need for accessible healthcare, while navigating complex intellectual property landscapes and ensuring rigorous quality control standards.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.